Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ImmunoSEB
- Development stage
- Unknown
- Lead developer
- Specialty Enzymes & Probiotics
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Oral
01
Overview
ImmunoSEB is a proprietary systemic enzyme complex developed by Specialty Enzymes & Probiotics, designed to support immune health and modulate inflammatory responses. The formulation consists of a synergistic blend of proteolytic and non-proteolytic enzymes, including bromelain, papain, peptidase, amylase, and lipase. Its primary mechanism of action involves the systemic absorption of these enzymes, which then act to degrade pro-inflammatory cytokines (such as IL-6 and TNF-alpha) and clear circulating immune complexes and cellular debris. This biocatalytic approach aims to prevent or mitigate excessive inflammatory states, such as the cytokine storm associated with viral infections. ImmunoSEB has been clinically evaluated, often in combination with probiotics like ProbioSEB CSC3, for its efficacy in reducing fatigue and promoting recovery in patients with COVID-19 and post-viral syndromes.
- Brand names
- ImmunoSEB
- Other names
- Systemic Enzyme Complex
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))Fibrin (Factor Ia)IL-6 (Interleukin 6)BK (Bradykinin)
Beyond the preview
Go deeper on ImmunoSEB.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImmunoSEB.